|
Currently available Therapy Area Reports include those on Atherosclerosis Drug Markets, Cardiovascular Drug Markets and CV Risk Factor Drug Markets. |
Interrelated pathogenesis, shared risk factors and confluent treatment populations create complex relationships between cardiovascular drug markets that challenge market planners, but also set up a unique landscape of new product opportunities where virtually every drug class has potential use for multiple indications. This report series captures these pervasive dynamics and market driving forces in a sophisticated and comprehensive two pronged cross-analysis of drug classes and disease areas, delivering practical and strategic assessments of opportunities and threats, across broad therapy areas comprised of highly interconnected market segments.
METHODOLOGY and CONTENTS
Based on extensive expert analysis of secondary research (scientific and medical publications, conferences, SEC filings etc.) each report includes therapy area analysis with incisive evaluations of disease etiology, pathophysiology, epidemiology, current treatment, unmet needs, pipeline developments, and market forecasts (10 year by indication and class) and drug area analysis with comprehensive assessments of mechanism of action (underlying scientific rationale, clinical relevance and theoretical potential to alter cardiovascular disease processes), current treatment (including FDA approved drugs, agents used off label and opportunities for expansion into new indications), pipeline developments, and 10 year market forecast.
|
|
Your message was received. Thank you for contacting us with your request.
Atherosclerosis Therapy Areas
Cardiovascular Therapy Areas
CV Risk Factor Therapy Areas
